Skip to main content
Salarius Pharmaceuticals, Inc. logo

Salarius Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SLRX ISIN · US79400X4043 LEI · 549300CLUMLZXIHU7X22 US Professional, scientific and technical activities
Open in API
Filings indexed 702 across all filing types
Latest filing 2019-03-06 Earnings Release
Country US United States of America
Listing US SLRX

About Salarius Pharmaceuticals, Inc.

https://salariuspharma.com/

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapies for cancer patients with high unmet medical needs. The company's core technology focuses on correcting the dysregulated gene expression of cancer cells, a key driver of disease development. Its pipeline includes two classes of drugs: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). The lead TPI candidate, seclidemstat (SP-2577), is in Phase 1/2 clinical trials, while the lead TPD candidate, SP-3164, is in IND-enabling studies. These therapeutic candidates are being developed to treat solid and hematologic cancers, including leukemias and lymphomas.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 6, 2019, by Flex Pharma, Inc. It announces the issuance of a press release regarding financial results for the year ended December 31, 2018. The document itself does not contain the financial results but references an attached press release (Exhibit 99.1). The length of the document is 3278 characters, which is relatively short and consistent with an announcement rather than a full report. The document explicitly states that the information is being furnished and not filed, and it is a current report on Form 8-K, which is typically used for unscheduled material events or corporate changes. Since this is an announcement of financial results and not the full earnings release or annual report itself, the appropriate classification is Earnings Release (ER).
2019-03-06 English
8-K
Delisting Announcement Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated February 12, 2019, by Flex Pharma, Inc. The content focuses on a notice of delisting or transfer of listing from the Nasdaq Global Market to the Nasdaq Capital Market due to the company's stock price falling below the minimum bid price requirement. It discusses the Nasdaq's approval for the transfer, the conditions for regaining compliance, and the potential for delisting if compliance is not met. This is a regulatory announcement about the company's stock listing status, not a financial report or earnings release. The key indicator is the section titled 'Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.' Therefore, the appropriate classification is a Delisting Announcement (DLST). The document length and detail confirm it is not a brief announcement but a formal regulatory filing about delisting.
2019-02-15 English
S-4
M&A Activity Classification · 100% confidence The document is a Form S-4 registration statement filed with the SEC, which is used for securities registration in connection with mergers and acquisitions. It includes detailed information about the merger agreement, stock issuance, and related corporate actions. The presence of terms like 'registration statement,' 'merger agreement,' 'issuance of common stock,' and 'proxy statement/prospectus/information statement' indicates this is a filing related to a merger transaction. The document is not an annual report, earnings release, or a simple announcement but a comprehensive merger-related filing. Therefore, the appropriate classification is 'M&A Activity' (TAR).
2019-02-14 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-12 English
PRIMARY DOCUMENT
Director's Dealing
2019-02-05 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-17 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.